UBS Group AG - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 25 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q3 2016$4,000
+300.0%
27,299
+922.8%
0.00%
Q2 2016$1,000
-50.0%
2,669
-83.6%
0.00%
Q1 2016$2,000
-33.3%
16,262
+984.1%
0.00%
Q4 2015$3,000
-57.1%
1,500
-59.5%
0.00%
Q3 2015$7,000
-12.5%
3,702
+9.6%
0.00%
Q2 2015$8,000
-77.1%
3,379
-57.6%
0.00%
Q1 2015$35,000
-49.3%
7,967
-44.0%
0.00%
Q4 2014$69,00014,2360.00%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q1 2016
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,644,705$27,357,0009.71%
First Washington CORP 194,440$1,145,0000.64%
SPHERA FUNDS MANAGEMENT LTD. 200,000$1,178,0000.29%
KINGDON CAPITAL MANAGEMENT, L.L.C. 286,801$1,669,0000.06%
EMERALD ADVISERS, LLC 175,000$1,031,0000.06%
Pine River Capital Management L.P. 209,900$1,236,0000.02%
Alyeska Investment Group, L.P. 82,943$489,0000.01%
TFS CAPITAL LLC 19,147$113,0000.01%
HighTower Advisors, LLC 66,514$392,0000.01%
DRIEHAUS CAPITAL MANAGEMENT LLC 32,143$189,0000.01%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders